Embryo rescue from seedless grapevines (<i>Vitis vinifera</i> L.) treated with growth retardants
DOI:
https://doi.org/10.5073/vitis.1995.34.73-76Keywords:
in ovulo culture, embryo rescue, ovule abortion, seedlessnessAbstract
The effects of two retardants (CCC and paclobutrazol) and the new compound XE 1019, applied before grapevine anthesis, were studied in order to increase the number of fertilised embryos and growing plantlets derived from in ovulo culture of seedless cultivars CG 102.011, Emperatriz and Malvinas. No significant differences were detected between treatments with CCC (400 and 800 mg . l-1, applied 2, 3 and 4 weeks before bloom), and the control in the cv. CG 102.011. The number of growing plantlets at 10 weeks after anthesis and at maturity was significantly higher than that from 8 weeks. In applications closer to bloom, CCC treatments increased the number of ovules per berry in the cultivars assayed. From all cultivars, only CG 102.011 showed a significant increase in plantlet production after CCC treatment when clusters were harvested the 10th week after bloom. It is believed that CCC would act through inhibition of endogenous gibberellin synthesis as the cause of ovule abortion. The idea is based on the fact that gibberellic acid can induce seedlessness in some seeded cultivars.Downloads
Published
Issue
Section
License
The content of VITIS is published under a Creative Commons Attribution 4.0 license. Any user is free to share and adapt (remix, transform, build upon) the content as long as the original publication is attributed (authors, title, year, journal, issue, pages) and any changes to the original are clearly labeled. We do not prohibit or charge a fee for reuse of published content. The use of general descriptive names, trade names, trademarks, and so forth in any publication herein, even if not specifically indicated, does not imply that these names are not protected by the relevant laws and regulations. The submitting author agrees to these terms on behalf of all co-authors when submitting a manuscript. Please be aware that this license cannot be revoked. All authors retain the copyright on their work and are able to enter into separate, additional contractual arrangements.